Binding and Presentation of Lipid Antigens by CD1

Project: Research project

Project Details

Description

We propose studies that will develop highly efficient methods for using synthetic glycolipids to activate and modulate the functions of a type of lymphocyte known as invariant Natural Killer T (iNKT) cells. The proposed work is strongly focused on the goal of developing clinically relevant iNKT cell-based therapies for cancer and other diseases.
StatusActive
Effective start/end date7/1/997/31/22

Funding

  • National Institute of Allergy and Infectious Diseases: $337,268.00
  • National Institute of Allergy and Infectious Diseases: $327,721.00
  • National Institute of Allergy and Infectious Diseases: $467,196.00
  • National Institute of Allergy and Infectious Diseases: $335,044.00
  • National Institute of Allergy and Infectious Diseases: $336,488.00
  • National Institute of Allergy and Infectious Diseases: $255,879.00
  • National Institute of Allergy and Infectious Diseases: $382,338.00
  • National Institute of Allergy and Infectious Diseases: $415,000.00
  • National Institute of Allergy and Infectious Diseases: $467,196.00
  • National Institute of Allergy and Infectious Diseases: $406,742.00
  • National Institute of Allergy and Infectious Diseases: $467,196.00
  • National Institute of Allergy and Infectious Diseases: $211,317.00
  • National Institute of Allergy and Infectious Diseases: $410,850.00
  • National Institute of Allergy and Infectious Diseases: $336,311.00
  • National Institute of Allergy and Infectious Diseases: $467,416.00
  • National Institute of Allergy and Infectious Diseases: $406,742.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.